News | October 25, 2024
Mankind Pharma completes acquisition of BSV
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
Aims to achieve CDMO sales of US$ 400 million by 2028
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Morepen Labs successfully raised Rs. 200 Crore through QIP
Subscribe To Our Newsletter & Stay Updated
